1. Australian Government Department of Health. The Australian Immunisation Handbook, 10th Edition 2013 (Updated June 2015) www.immunise.health.gov.au
2. NSW Health. Antenatal Pertussis Vaccination: NSW Public Hospital Antenatal Clinic Guidelines. August 2015.
3. Australian Government Department of Health and Aging. National Vaccine Storage Guideline-Strive for Five. 2nd Edition. 2013.
4. MIMS online available via CIAP. Accessed 9/3/16
5. Product Monograph: INFANRIX® hexa. ©2015 GlaxoSmithKline Inc., All Rights Reserved
6. Dhillon S. DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination. Drugs 2010; 70(8): 1021-58.
7. Ome~naca F, Vazquez L, Garcia-Corbeira P, et al. Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: a review of safety and immunogenicity. Vaccine 2018;36(7):986e96. https://doi.org/10.1016/j.vaccine.2018.01.005.
8. Esposito S, Faldella G, Giammanco A, Bosis S, Friscia O, Clerici M, et al. Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants. Vaccine 2002;20:2928e32. https://doi.org/10.1016/S0264-410X(02)00230-X. PMID:12126904
9.Freitas da Motta MS, Mussi-Pinhata MM, Jorge SM, Tachibana Yoshida CF, Sandoval de Souza CB. Immunogenicity of hepatitis vaccine in preterm and full term infants vaccinated within the first week of life. Vaccine 2002;20(11e12):
1557e62. https://doi.org/10.1016/S0264-410X(01)00493-5.
10. Blondheim O, Bader D, Abend M, Peniakov M, Reich D, Potesman I, et al. Immunogenicity of hepatitis B vaccine in preterm infants. Arch Dis Child Fetal Neonatal 1998;79:F206.
11. Baldo V, Bonnani P, Castro M & et al. Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b vaccine – Infanrix hexa. Human Vaccines & Immunotherapeutics 2014; 10 (1): 129-137.
12. European Medicines Agency. Infanrix hexa: summary of product characteristics [online].
| 